Account
Inquiry
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide has shown promising results in clinical studies for the treatment of type 2 diabetes and obesity.
Our tirzepatide is produced under strict quality control standards, ensuring high purity and consistent performance for research applications. The product is supplied in lyophilized form and should be stored frozen at -20°C or below to maintain stability.
Key features of our tirzepatide include pharmaceutical grade purity, batch-to-batch consistency, and comprehensive analytical documentation. The product is available in various concentrations to meet different research requirements.
As with all our peptide products, this material is intended for research purposes only and not for human consumption. Researchers should follow proper handling procedures and safety protocols when working with tirzepatide.
We offer flexible ordering options including small quantities for preliminary studies and bulk quantities for larger research projects. Our manufacturing capabilities allow for custom formulations and concentrations to meet specific research needs.
